Publications by authors named "Philippe Henon"

Claim this Profile
T
Transendocardial Injection of Expanded Autologous CD34+ Cells After Myocardial Infarction: Results of the EXCELLENT Trial.
Jerome Roncalli, François Roubille, Yves Cottin, Lionel Leroux, Anthony Mathur, Philippe Henon

JACC Heart Fail· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a potency assay for CD34 + cell based therapy.
Christine Vignon, Arthur Cormier, Aurélien Goubaud, Hélène Schaffhauser, Sara Bennaoum

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon

ESC Heart Fail· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming Perspectives in Cardiac Cell Therapy: Hypothesis and Commentary Following Updated Results of a Pilot Study Investigating Very Long-Term Clinical Outcomes in Severe AMI Patients Following Trans-Epicardial Injection of Peripheral Blood CD34 Cells.
Philippe Hénon, Nicolas Bischoff, Robert Dallemand

Stem Cell Rev Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a potency assay for CD34 cell-based therapy.
Anne Aries, Christine Vignon, Céline Zanetti, Aurélien Goubaud, Arthur Cormier

Sci Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of expanded peripheral blood derived CD34+ cells for the treatment of moderate knee osteoarthritis.
Christine Vignon, Morgane Hilpert, Karine Toupet, Aurélien Goubaud, Danièle Noël

Front Bioeng Biotechnol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the Cardiovascular Potential of Human CD34 Stem Cells.
Anne Aries, Céline Zanetti, Philippe Hénon, Bernard Drénou, Rachid Lahlil

Int J Mol Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Industrialized GMP Production of CD34 Cells (ProtheraCytes®) at Clinical Scale for Treatment of Ischemic Cardiac Diseases Is Feasible and Safe.
Philippe Hénon, Marc Kowalczyk, Anne Aries, Christine Vignon, Guillaume Trébuchet

Stem Cell Rev Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Expression of the Tetraspanin CD9 in Normal and Leukemic Stem Cells.
Rachid Lahlil, Maurice Scrofani, Anne Aries, Philippe Hénon, Bernard Drénou

Biology (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key Success Factors for Regenerative Medicine in Acquired Heart Diseases.
Philippe Hénon

Stem Cell Rev Rep· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Validation of an Automated Process for the Expansion of Peripheral Blood-Derived CD34 Cells for Clinical Use After Myocardial Infarction.
Claire Saucourt, Sandrine Vogt, Amandine Merlin, Christophe Valat, Anthony Criquet

Stem Cells Transl Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VSELs Maintain their Pluripotency and Competence to Differentiate after Enhanced Ex Vivo Expansion.
Rachid Lahlil, Maurice Scrofani, Romain Barbet, Céline Tancredi, Anne Aries

Stem Cell Rev Rep· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Very Small Embryonic-Like Stem Cells Are Present in Normal Peripheral Blood of Young, Middle-Aged, and Aged Subjects.
Hanna Sovalat, Maurice Scrofani, Antoinette Eidenschenk, Philippe Hénon

Stem Cells Int· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy.
Céline Schmitt, Manon Voegelin, Aurélie Marin, Marjorie Schmitt, Fabienne Schegg

Bioorg Med Chem· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
Hanna Sovalat, Maurice Scrofani, Antoinette Eidenschenk, Stéphanie Pasquet, Valérie Rimelen

Exp Hematol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct.
Stéphanie Pasquet, Hanna Sovalat, Philippe Hénon, Nicolas Bischoff, Yazid Arkam

Cytotherapy· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional distribution patterns of CD34 antigen on nonactivated cord blood cells.
Georges Jung, Eckart Wunder, Alain Dieterlen, Philippe Hénon, Serge Jacquey

Cytometry A· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human embryonic or adult stem cells: an overview on ethics and perspectives for tissue engineering.
Philippe R Henon

Adv Exp Med Biol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell surface CD43 determination improves diagnostic precision in late B-cell diseases.
Georges Jung, Jean-Claude Eisenmann, Sylvie Thiébault, Philippe Hénon

Br J Haematol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis